MARKET

CRSP

CRSP

Crispr Therapeut
NASDAQ
49.24
-1.19
-2.36%
Opening 12:21 02/21 EST
OPEN
51.23
PREV CLOSE
50.43
HIGH
51.47
LOW
49.05
VOLUME
898.12K
TURNOVER
--
52 WEEK HIGH
91.10
52 WEEK LOW
36.52
MARKET CAP
4.22B
P/E (TTM)
-11.3414
1D
5D
1M
3M
1Y
5Y
1D
CRISPR set to snap six days of gains as shares trade in red
Seeking Alpha · 22h ago
Cantor Fitzgerald Reiterates Neutral on CRISPR Therapeuticsto Neutral
Benzinga · 2d ago
Crispr Therapeutics Price Target Cut to $82.00/Share From $89.00 by Citigroup
Dow Jones · 3d ago
Crispr Therapeutics Is Maintained at Buy by Citigroup
Dow Jones · 3d ago
Citigroup Maintains Buy on CRISPR Therapeutics, Lowers Price Target to $82
Benzinga · 3d ago
Unusually active option classes on open February 18th
TipRanks · 3d ago
CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?
NASDAQ · 3d ago
This Bath & Body Works Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Benzinga · 3d ago
More
About CRSP
More
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.
Recently
Symbol
Price
%Change

Webull offers Crispr Therapeutics AG stock information, including NASDAQ: CRSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRSP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRSP stock methods without spending real money on the virtual paper trading platform.